Henkel Expands Medical Wearables Portfolio

From smart health patches to continuous glucose monitors and smart glasses, the use of medical wearables and consumer wearables for remote monitoring has increased dramatically in recent years. The shift from hospital care to remote home care has led to a demand in remote tracking and diagnostics. Devices are smaller, require better environmental protection and reliable diagnostics, while maintaining patient safety and comfort. These advancements in medical device design require innovative solutions to optimize devices and processes beyond today’s level of care. 

Henkel’s adhesives and electronic materials have for decades facilitated the design and manufacture of medical devices engineered to streamline diagnostics and improve patient outcomes. The company´s materials know-how and industry expertise has fostered the co-development and support of medical solutions for caregivers and patients to improve quality of care and life. 

Henkel has now expanded its healthcare wearables portfolio, encompassing high-impact solutions for low pressure molding technologies, skin bonding, assembly adhesives and electronics and printed electronics.

Recently, the company worked to adapt a molding technology that was traditionally used in industrial electronics for wearable medical applications. The new technology is medical grade and skin safe and replaces the typical clamshell housing, that requires multiple components and assembly steps, with a single step over-mold design. With this technology Henkel offers a significant process saving step that contributes to lower production cost, especially when there is a high volume of production. 

“At Henkel, we believe that offering a comprehensive portfolio of products and solutions to our customers is the sustainable way to drive innovation and growth for businesses,” explained Philipp Loosen, head of Industrials EIMEA and Global Key Accounts Medical at Henkel. “We are proud to expand our product portfolio of medical wearables into the market to further support our customers and eco-system partners with an efficient and reliable healthcare solution. With our products and technologies, we help to redefine the way people access and monitor their health.” 

Henkel’s Medical Device Adhesives are tested to ISO 10993 biocompatibility standards. In addition, the company employs strict manufacturing and quality controls to ensure continuity of compliance. 

With its brands, innovations and technologies, Henkel holds leading market positions worldwide in the industrial and consumer businesses. The Adhesive Technologies business unit is al leader in adhesives, sealants and functional coatings and its Consumer Brands is competitive in various categories. The company’s fiscal 2022 sales exceeded €22 billion and its adjusted operating profit totaled about €2.3 billion. Henkel’s preferred shares are listed in the German stock index DAX. Henkel was founded in 1876 and today employs more than 50,000 people worldwide.